IP Library Assignment 053736/0541
Patent Assignment
Reel/Frame 053736/0541

Assignment of Assignor's Interest

Recorded: 2020-09-10 Pages: 3
Assignor
ASCENDIS PHARMA GMBH
Executed: 2020-09-07
Assignee
ASCENDIS PHARMA A/S
TUBORG BOULEVARD 5, HELLERUP, 2900, DENMARK
Covered Property (1)
PEGylated Recombinant Human Growth Hormone Compounds
Application: 15/000,242 →
Publication: US 2016/0206702
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name Nov 5, 2019
From: ASCENDIS PHARMA GROWTH DISORDERS DIVISION A/S
To: ASCENDIS PHARMA ENDOCRINOLOGY DIVISION A/S
Reel/Frame 050930/0474 →
Assignment of Assignor's Interest Sep 10, 2020
From: RAU, HARALD, DR.; KINDERMANN, SUSANNE, DR.; LESSMANN, TORBEN, DR.; HERSEL, ULRICH, DR.
To: ASCENDIS PHARMA GMBH
Reel/Frame 053735/0911 →
Assignment of Assignor's Interest Sep 10, 2020
From: RASMUSSEN, GRETHE NØRSKOV; SPROGØE, KENNETT, DR.
To: ASCENDIS PHARMA A/S
Reel/Frame 053736/0726 →
Assignment of Assignor's Interest Sep 10, 2020
From: ASCENDIS PHARMA A/S
To: ASCENDIS PHARMA ENDOCRINOLOGY DIVISION A/S
Reel/Frame 053736/0894 →